The cystic fibrosis transmembrane conductance regulator (CFTR) undergoes rapid turnover at the plasma membrane in various cell types. The ubiquitously expressed N-WASP promotes actin polymerization and regulates endocytic trafficking of other proteins in response to signaling molecules such as Rho-GTPases. In the present study we investigated the effects of wiskostatin, an N-WASP inhibitor, on the surface expression and activity of CFTR. We demonstrate, using surface biotinylation methods, that the steady-state surface CFTR pool in stably transfected BHK cells was dramatically decreased following wiskostatin treatment with a corresponding increase in the amount of intracellular CFTR. Similar effects were observed for latrunculin B, a specific actin-disrupting reagent. Both reagents strongly inhibited macroscopic CFTR-mediated Cl − currents in two cell types including HT29-Cl19A colonic epithelial cells. As previously reported, CFTR internalization from the cell surface was strongly inhibited by a cyclic-AMP cocktail. This effect of cyclic-AMP was only partially blunted in the presence of wiskostatin, which raises the possibility that these two factors modulate different steps in CFTR traffic. In kinetic studies wiskostatin appeared to accelerate the initial rate of CFTR endocytosis as well as inhibit its recycling back to the cell surface over longer time periods. Our studies implicate a role for N-WASPmediated actin polymerization in regulating CFTR surface expression and channel activity.
Introduction
The cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride-selective ion channel found in epithelial cells lining the gastrointestinal tract, airways and reproductive organs. Mature, glycosylated CFTR is delivered from post-golgi compartments to the apical plasma membrane where it regulates the vectorial transport of ions and water across the cell membrane. Interestingly, the wild type protein has a relatively long half-life (16-24 h in most cell types), although it exhibits rapid turnover (within minutes) at the surfaces of many cell types [1, 2] . Biochemical, biophysical and functional studies of T84 colonic epithelial cells and stably transfected Chinese hamster ovary cells provided evidence that CFTR is rapidly internalized from the plasma membrane by clathrin-coated vesicles [2, 3] . The C-terminal tail of CFTR contains two structural features that are important for its endocytosis; (i) a dileucine ( 1430 LL) motif and (ii) a tyrosine-based motif ( 1424 YDSI 1427 ). The latter motif interacts with the clathrin adapter protein complex (AP-2), which facilitates entry of the ion channel into coated pits [4, 5] . Internalized CFTR channels appear to be capable of rapidly recycling back to the plasma membrane, presumably via recycling endosomes [6] , which could possibly modulate CFTR expression at the cell surface [7] . However, the mechanism and itinerary of CFTR recycling is not fully understood.
Several studies indicate that the components of the clathrinmediated endocytic machinery directly or indirectly interact with the actin cytoskeleton, which forms a scaffolding structure beneath the plasma membrane [8, 9] . Disruption of the actin filament network has been demonstrated to compromise the endocytic trafficking of some proteins such as the transferrin receptor [10] and H + -K + -ATPase proton pumps [11] ; however, others have reported no effect on clathrin-mediated endocytosis [12, 13] . Recently, Swiatecka-Urban et al., have reported that CFTR interacts with a complex of actin-binding proteins including myosin VI that facilitate CFTR endocytosis and that may regulate CFTR expression at the cell surface [14] . In addition it was reported that CFTR-mediated Cl − currents were insensitive to stimulation by cyclic-AMP in whole cells or to direct addition of PKA to excised patches when the actin cytoskeleton was first completely disrupted [15, 16] . The authors proposed that a direct interaction between the actin filaments and CFTR was a prerequisite for stimulating channel activity.
In the present study we investigated the effects of two actindisrupting reagents, namely, wiskostatin and latrunculin B, on regulating the surface expression and activity of CFTR. Wiskostatin is a cell-permeant compound that stabilizes NQWASP in its native, autoinhibited conformation thereby preventing actin polymerization [17] [18] [19] . The WASP family proteins are emerging as central regulators of actin assembly vis-à-vis their interactions with Rho family GTPases, phosphatidylinositol 4,5 bisphosphate (PIP 2 ) and Arp2/3 complexes. Moreover, several studies indicate that N-WASP regulates endocytosis and exocytosis, presumably via its role in modulating actin assembly [20] [21] [22] . Latrunculin B, which causes actin filament disassembly by sequestering actin monomers, was reported to block the recycling of G-protein coupled receptors internalized in response to β-agonists in human carcinoma cells [23] .
We show that wiskostatin substantially reduced the steadystate surface pool of CFTR in biochemical studies in which cell surface CFTR was labeled using a cleavable biotinylating reagent (NHS-SS-biotin). Concomitantly, there was a dramatic increase in the amount of CFTR that accumulated within the cells following wiskostatin treatment although the total CFTR content in the lysates was not appreciably altered. Similar results were obtained using latrunculin B. Both wiskostatin and latrunculin B also dramatically decreased CFTR-mediated currents in two cell types including HT29-Cl19A colonic epithelial cells. In detailed kinetic studies we observed that wiskostatin had complex effects on both the time course of CFTR endocytosis and recycling implying that it may affect both processes. Our results indicate that the filamentous actin and/or N-WASP-dependent actin assembly play a modulatory role in the endocytic trafficking of CFTR.
Materials and methods

Cell culture
BHK cells that were stably transfected with full-length wild-type human CFTR were a gift from J.W. Hanrahan and cultured as described [24] . HT29-CL19A human colonic epithelial cells expressing native CFTR were propagated as described previously [25] .
Cell surface biotinylation
Cell surface proteins were biotinylated with sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate (sulfo-NHS-SS-Biotin) following previously published protocols [2] with minor modifications. Briefly, BHK-CFTR cells grown in 100-mm dishes were incubated with indicated concentrations of wiskostatin (Calbiochem) or DMSO (vehicle) for 2 h at 37°C. Further steps were performed at 0°C. Cells were rinsed with ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , pH 7.4) containing 0.1 mM CaCl 2 and 1 mM MgCl 2 (PBS-CM) and incubated with 1 mg/ml EZ-Link Sulfo-NHS-SS-biotin (Pierce) in PBS (pH adjusted to 8.0) for 30 min. Cell monolayers were rinsed with cold PBS-CM and unreacted biotin molecules were quenched with PBS containing 1% BSA for 10 min before cell lysis and streptavidinagarose capture.
CFTR internalization assay
To assay the internalization of cell surface CFTR, cell surface proteins were biotinylated as above, after which the cells were warmed to 37°C for varying time periods in the presence of wiskostatin, latrunculin B (Calbiochem) or DMSO (vehicle). In some experiments a cyclic-AMP cocktail (100 μM cptcAMP, 20 μM forskolin, 1 mM IBMX) was added to the cells at this stage. At the indicated time points, cells were rapidly cooled by rinsing with cold PBS-CM and biotin molecules exposed at the cell surface were cleaved with a membrane impermeant stripping solution (100 mM MESNA (mercaptoethanesulfonic acid; Sigma), 50 mM Tris, 100 mM NaCl, 1 mM EDTA, 0.2% (w/v) BSA, adjusted to pH 8.0). Cells were treated with 3 changes of stripping solution for 15 min each on ice to ensure complete removal of surface-exposed biotin. Stripped cells were rinsed with cold PBS-CM and processed for lysis.
Cell lysis, streptavidin-agarose capture and immunoblotting
Cells were lysed with 1 ml PBS containing 1% (v/v) Triton X-100 and protease inhibitor cocktail (Roche). Lysates were centrifuged (10,000×g) to remove cell debris and protein concentrations of clarified lysates were estimated by standard micro-BCA protein assay (Pierce). Equivalent amounts of cell lysates (2 mg) were rotated with 50 μl of packed streptavidin-agarose (Novagen) overnight at 4°C. The streptavidin-agarose beads were washed extensively with lysis buffer and bound proteins were eluted with Laemmli buffer and separated by SDS-PAGE on 4-15% gradient gels (Bio-Rad) followed by immunoblotting on polyvinylidene difluoride membranes (Millipore). CFTR protein was detected using monoclonal antibodies against the C-terminal tail (clones 24-1, R&D Research and GA-1, Santa Cruz Biotech.) and protein bands were visualized by enhanced chemiluminescence (Pierce). Signals were quantified by densitometric scanning followed by analysis with Scion Image (release beta 4.0.2) (Scion Corp.).
Electrophysiology
BHK-CFTR cells were grown on plastic coverslips for excised inside-out patch clamp recordings. Patch pipettes were pulled to tip resistances of 3-4 mOhm. CFTR channels were activated following patch excision by PKA catalytic subunit (110 U/ml) and 1.5 mM Mg 2+ -ATP. Macroscopic currents were recorded in symmetrical solutions containing (in mM): 140 N-methyl-Dglucamine-Cl, 3 MgCl 2 , 1 EGTA and 10 TES (pH 7.3). Experiments were performed at 21-23°C. Currents were evoked using a voltage ramp protocol from +80 to −80 mV with a 10 s time period. Data acquisition was performed using pCLAMP9 software (Axon Instruments).
Whole-cell recordings were obtained from HT29-Cl19A cells using methods as previously described [26] and solutions in which Cl − was the only permeant species as previously described for epithelial cells [25] . All experiments were conducted at room temperature (22-24°C) using an EPC-9 patch clamp amplifier (HEKA Electronik GmbH, Germany) and using the Pulse + PulseFit V 
Data analysis and statistics
Each experiment was repeated at least 3 times. The data are expressed as the means ± S.E. Statistical analysis was performed using student's unpaired t test (two-tailed) to compare the means, and significance was determined at p < 0.05.
Results
Wiskostatin decreases steady-state levels of surface CFTR
BHK-CFTR cells were incubated at 0°C with NHS-SSbiotin in order to label CFTR at the cell surface. This reagent covalently binds to extracellular residues (most likely lysines) on surface proteins (see Materials and methods) and has been used extensively to label surface CFTR [2, 27] . In the initial experiments we determined the dose of wiskostatin that produced a maximal effect on CFTR expression at the cell surface. Previous in vitro studies have reported that wiskostatin binds to WASP fragments with an apparent K d ∼ 100 μM [17] . We observed that the actin cytoskeleton was disrupted in > 90% of cells treated with this dose of wiskostatin for 2 h by staining with phalloidin-alexa-fluor-488 (not shown). Therefore, BHK-CFTR cells were treated with 0-100 μM wiskostatin for 2 h prior to biotinylation and subsequent cell lysis. Incubating cells for longer time periods or with higher concentrations resulted in loss of cell adherence that interfered with subsequent washing and processing steps. Biotinylated proteins were captured with streptavidin-agarose beads following cell lysis and CFTR was detected using monoclonal antibodies to its C-terminal tail. Total CFTR was detected by directly immunoblotting the cell lysates. As shown in the panel representing the streptavidin-bound fraction of CFTR (Fig. 1A , upper panel), there was a dose-dependent decrease in the surface CFTR signal in the presence of wiskostatin. We determined by densitometry (Fig. 1B ) that about 80% of the CFTR signal was lost from the cell surface at the highest dose of wiskostatin (100 μM) as compared to vehicle control. There was, however, no appreciable change in the total CFTR content in the lysates at all doses of wiskostatin (Fig. 1A , lower panel). From these results it is clear that wiskostatin causes a substantial decrease in CFTR levels at the cell surface but does not alter the total CFTR content of cells (at least for the time and doses used in this study).
Wiskostatin and latrunculin B cause CFTR to accumulate within cells
Since the preceding results indicated that CFTR was removed from the cell surface following wiskostatin treatment, we next examined the fate of the internalized protein in these cells (Fig. 2 ). Since N-WASP is known to regulate actin assembly in cells, we also tested the effects of a known actindisrupting reagent, namely, latrunculin B on the fate of CFTR. In these experiments BHK-CFTR cells were first incubated with NHS-SS-biotin on ice (to inhibit endocytosis) and then incubated in the presence or absence of wiskostatin or latrunculin B for 2 h at 37°C. During this warming period the cell surface proteins are continuously endocytosed and recycled and reach a new steady-state distribution between the cell surface and intracellular compartments (refer to detailed time-course experiments in Fig. 6 ). Next, the labeled proteins that were surface exposed at steady-state were stripped with a membrane-impermeant reducing reagent, MESNA [2] . The stripping efficiency was determined to be > 95% for control cells that were not warmed to 37°C (see Fig. 2B ). Biotinylated proteins were captured with streptavidin-agarose and immunoblotted with CFTR antibodies to detect the fraction of initially labeled CFTR that was present inside the cells at steady-state. We observed a dose-dependent increase in the amount of labeled CFTR that accumulated in the cells at steady-state in the presence of wiskostatin; >80% of the surface-labeled CFTR accumulated inside the cells at 100 μM wiskostatin as compared to ∼30% in control (vehicle-treated) cells over a period of 2 h. Similarly, in the presence of 10 μM latrunculin B, 60-70% of surface-biotinylated CFTR accumulated in the cells at steady-state ( Fig. 2A, B) . The IC 50 for latrunculin B is typically in the submicromolar range, and at doses > 10 μM was toxic to the cells. Again there was no change in the CFTR content in the lysates at all doses of wiskostatin or latrunculin B. Together with the results shown in Fig. 1 , these data indicate that wiskostatin and latrunculin caused CFTR to dramatically relocate from the cell surface to intracellular compartments.
We also observed that latrunculin B showed a tendency to reduce steady-state CFTR expression at the cell surface using the assay of Fig. 1 , but the results obtained with this compound were not as reproducible as with wiskostatin (not shown). This disparity could be due to the fact that these reagents have different molecular targets and/or that wiskostatin has a more consistent effect on actin organization.
Wiskostatin and latrunculin B decrease CFTR-mediated currents in BHK membrane patches and in HT29 colonic epithelial cells
The preceding results indicate that macroscopic CFTR currents should be reduced by wiskostatin if it indeed causes CFTR to redistribute from the cell surface to the cell interior. In order to test this prediction we performed two complementary functional assays in different cell types, (i) macroscopic excised patch clamp experiments in BHK-CFTR cells expressing high levels of recombinant human CFTR and (ii) whole-cell patch clamp studies in HT29-Cl19A human colonic epithelial cells expressing low levels of native CFTR. The BHK-CFTR cells were pre-treated with wiskostatin following which inside-out membrane patches were excised using large tip pipettes. CFTRmediated currents were activated by adding normally saturating concentrations of PKA and Mg-ATP to the bath. In control patches excised from untreated cells, the CFTR-mediated currents were of typically high magnitude (> 400 pA; Fig. 3A ) due to the presence of several hundred CFTR channels per patch [28] . The fact that the elicited currents were (i) Mg-ATPdependent (not shown) and (ii) inhibited by addition of the voltage-dependent pore-blocker glibenclamide (see Fig. 3A ) confirmed that the currents were CFTR-mediated. By comparison, the PKA-activated and Mg-ATP-dependent currents were consistently much smaller for membrane patches excised from wiskostatin-treated cells (Fig. 3B, C) as also for membrane patches excised from cells pre-treated with latrunculin B (Fig. 3C) . The low magnitude of the CFTR-mediated currents indicated that the number of channels in the patch was drastically reduced and/or that the existing channels had very low activity. Because the biochemical results indicated that wiskostatin substantially decreases the number of CFTR molecules at the cell surface, one explanation is that the reduced currents are due to a decrease in the channel density at the plasma membrane. However, it is worth noting that CFTRmediated currents were inhibited by up to 80% (Fig. 3C ) by a dose of wiskostatin (5 μM) that did not produce an equivalent decrease in surface-labeled CFTR (see Fig. 1 ) (membrane patches could not be reliably obtained at higher doses of wiskostatin). This disparity may be due to the different conditions under which these two assays were performed. In order to test the possibility that wiskostatin could possibly affect the regulatory properties of CFTR as well, wiskostatin (5 μM) was added directly to the cytoplasmic side of excised membrane patches (results not shown). We did not observe an acute reduction of CFTR-mediated currents under these circumstances, indicating that wiskostatin does not directly affect the gating properties of CFTR channels (see Discussion).
In a complementary set of experiments, CFTR-mediated currents were recorded in HT29-Cl19A epithelial cells under control (untreated) or wiskostatin-treated conditions by wholecell patch clamp analysis (Fig. 4) . These cells express native CFTR and probably represent a more physiologically relevant system for recording CFTR activity. However, these cells express very modest levels of CFTR which makes it difficult to conduct biochemical studies such as surface biotinylation.
CFTR-mediated Cl
− currents were activated by addition of a cyclic-AMP-cocktail. These currents were validated to be CFTR-mediated on the basis of their dependence on cyclic-AMP activation and block by 1 mM glibenclamide or DPC (not shown). The cyclic-AMP-activated currents were substantially reduced for wiskostatin-treated cells (Fig 4A, B) . Likewise, treatment with latrunculin B also inhibited CFTR-mediated currents in the HT29-Cl19A cells (Fig. 4A, B) . The results of the biochemical (surface biotinylation assays) and functional studies indicate that wiskostatin and latrunculin B have striking effects on both the surface expression and macroscopic functional activity of CFTR channels.
Cyclic-AMP inhibits CFTR internalization in the presence or absence of wiskostatin
Cyclic-AMP has been reported to inhibit CFTR endocytosis, presumably, because the active channel is not efficiently internalized or that protein phosphorylation alters the recycling of CFTR [1, 2] . In this context we examined the effects of wiskostatin on CFTR accumulation in cells in the presence of a cyclic-AMP cocktail (Fig. 5) . BHK-CFTR cells were first biotinylated at 4°C and then exposed to 100 μM wiskostatin in the presence or absence of a cyclic-AMP cocktail for 2 h at 37°C
. Following this, the cells were stripped of surface biotin and the fraction of labeled CFTR that accumulated inside the cells at steady-state was assessed by streptavidin capture and immunoblotting. As previously reported, a smaller fraction of labeled CFTR accumulated inside the cells in the presence of cyclic-AMP as compared to control untreated cells (Fig. 5A) . Cyclic-AMP also reduced CFTR internalization in the presence of wiskostatin, although a greater fraction of CFTR was internalized than with cyclic-AMP alone (Fig. 5A, B) . These data indicate that cyclic-AMP inhibits CFTR internalization even in the presence of wiskostatin, which implies that these two factors may regulate different steps in CFTR traffic.
Wiskostatin has complex effects on the kinetics of CFTR internalization and recycling
From the preceding results it is apparent that wiskostatin has pronounced effects on CFTR expression at the cell surface. CFTR channel density at the plasma membrane reflects a balance between the rates of CFTR endocytosis and recycling back to the cell surface. Detailed time course experiments were performed to determine if wiskostatin primarily affected the rate of CFTR endocytosis. BHK-CFTR cells were treated with 100 μM wiskostatin for 2 h following which cells were surfacebiotinylated at 0°C and then warmed to 37°C for varying times (0-30 min). At each time point the surface biotin was stripped with MESNA and the biotinylated CFTR inside the cells was detected by streptavidin-capture and immunoblotting as described (Fig. 6A) . In the control cells (no wiskostatin) there was a quasi-linear increase in the fraction of CFTR that accumulated in the cells between 0 and 2 min. At longer times there was no apparent increase in the CFTR signal, presumably because the internalized CFTR is rapidly and efficiently recycled back to the cell surface (Fig. 6B ). Two differences were observed for cells treated with wiskostatin: (i) a larger fraction of surfacelabeled CFTR was internalized in the first 2 min and (ii) the biotinylated CFTR continued to accumulate in the cells over a longer period and reached steady state more gradually as compared to control (Fig. 6B) . These data indicate that wiskostatin may have multiple effects on CFTR endocytosis/ recycling: (i) an increase in the initial rate of CFTR internalization (caused either by an increase in the fraction of labeled CFTR molecules that can be internalized, or an increase in the intrinsic rate of endocytosis) and (ii) a reduction in the rate of recycling of internalized CFTR molecules back to the cell surface (evidenced as a slower time-course to reach steady-state).
Discussion
CFTR is present largely at the plasma membranes of epithelial cells where it regulates bidirectional transport of ions and water. The carboxy-terminal tail of CFTR contains signals that facilitate its entry into clathrin-coated pits [5] and it is well documented that the channel is constitutively internalized in various cell types [1, 2] . The main goal of this work was to determine if CFTR levels at the cell surface are modulated by actin polymerization and/or N-WASP-mediated actin assembly. We investigated the steady-state distribution of CFTR between the plasma membrane and intracellular compartments in response to latrunculin B, an actin depolymerizing agent and wiskostatin, a cell-permeable allosteric inhibitor of N-WASP that effectively blocks actin assembly. The WASP family proteins together with the Arp2/3 complex are key modulators of actin assembly in various cell types. The WASP family proteins are direct effectors for upstream signaling molecules, namely, Rho-GTPases and PIP 2 , which regulate many aspects of cell function including vesicle trafficking. Further, the Rho-GTPases are preferred targets for toxins secreted by opportunistic pathogens, including Pseudomonas aeruginosa, that cause life-threatening infections in cystic fibrosis patients. Through modulation of Rho-GTPases activity the pathogens mediate changes in the actin cytoskeleton which may facilitate their entry in cells [29] . In this context it was recently reported that a cell-free filtrate of P. aeruginosa reduced CFTR-mediated transepithelial Cl − secretion by inhibiting the endocytic recycling of CFTR in polarized human airway epithelial cells [30] . Our results raise the possibility that physiologic and pathologic factors that influence WASP activity may modify CFTR expression or functional activity at the plasma membrane. Future studies will be aimed at identifying such factors and determining their role in regulating CFTR surface expression and activity.
CFTR surface expression and activity are reduced by wiskostatin and latrunculin B
We observed a dose-dependent decrease in CFTR surface expression following wiskostatin treatment of BHK-CFTR cells in biotinylation studies. A large fraction of CFTR (∼80%) was lost from the cell surface at 100 μM wiskostatin. There was no change in the total CFTR content in the lysates at all doses of wiskostatin indicating that there was no apparent degradation of CFTR under these conditions. The steady-state surface CFTR expression presumably reflects a balance between rates of internalization and of recycling back to the cell surface. Our results indicate that both wiskostatin and latrunculin B shifted the steady-state distribution towards greater amounts of CFTR inside cells while depleting the ion channel from the cell surface (Fig. 2) . Similar results were also obtained with cytochalasin D, a standard actin-disrupting reagent that binds to the growing ends of the actin filaments (unpublished observations). However, the effect of wiskostatin was most consistent and reproducible in these experiments.
The biochemical results were corroborated by functional studies performed in cultured cells. CFTR-mediated Cl − currents were strongly inhibited by wiskostatin and latrunculin B both in BHK fibroblast cells that express high levels of recombinant CFTR and in HT29-CL19A epithelial cells that express low levels of native CFTR. The correlation between the results of the biochemical and functional studies favors the idea that these reagents greatly reduce the number of CFTR channels expressed at the cell surface. However, we observed that the dose of wiskostatin required to inhibit CFTR-mediated currents by > 80% in membrane patches excised from BHK-CFTR cells (5 μM; Fig. 2 ) was less than the dose which resulted in 80% reduction in surface CFTR expression biochemically (100 μM; Fig. 1 ). One possible explanation is that the readouts for the surface biotinylation assay and the functional (patch clamp) assay cannot be directly compared, because the assays are performed under different conditions (intact cells versus broken cell assays) that may differently affect the actin cytoskeleton. However, we cannot rule out that the reagent could affect the regulation of individual CFTR channels as well. It seems unlikely that wiskostatin directly inhibits CFTR channels given that (i) wiskostatin binds to its specific target (N-WASP) in vitro with an apparent K d of ∼ 100 μM [17] and (ii) adding wiskostatin directly to the cytoplasmic side of excised membrane patches did not result in an acute reduction of CFTR-mediated currents. This, however, does not rule out other possibilities that have been proposed in the literature such as (i) CFTR activity is modulated by a direct interaction with actin filaments [31] or (ii) wiskostatin indirectly affects CFTR gating within intact cells by releasing a cellular kinase or phosphatase inhibitor that is tethered to F-actin filaments [32] .
Cyclic-AMP inhibits CFTR internalization in the presence or absence of wiskostatin
There is a growing notion that phosphorylation of the CFTR channel and/or its functional activity can modulate its surface expression in some cell types. Prince et al., demonstrated that stimulation with cyclic-AMP decreased the internalization of CFTR from the cell surface by ∼ 60% in T-84 epithelial cells [1] . Lukacs et al., similarly reported that activation of PKA inhibited the rate of CFTR endocytosis in stably transfected Chinese hamster ovary cells [2] . Other investigators postulated that cyclic-AMP also stimulated exocytosis/recycling of CFTR to the cell surface [7] . Thus, cyclic-AMP could affect CFTR expression at the cell surface by (i) inhibiting endocytosis or (ii) enhancing recycling. In the present study we observed that cyclic-AMP inhibited CFTR internalization both in the presence and absence of wiskostatin, although this effect was partially attenuated by wiskostatin (Fig. 5) . The results indicate that (i) wiskostatin and cyclic-AMP have opposite effects on CFTR expression at the cell surface and (ii) cyclic-AMP can partially override the effects of wiskostatin on CFTR internalization (or recycling; see below). It seems plausible that wiskostatin and cyclic-AMP primarily affect different steps in CFTR trafficking; on the one hand CFTR is endocytosed more slowly from the cell surface (as an effect of cyclic-AMP), whereas wiskostatin inhibits recycling of the internalized CFTR (see below). This could possibly explain the greater accumulation of CFTR inside cells in the presence of both cyclic-AMP and wiskostatin.
Models to explain effects of wiskostatin on CFTR surface expression
The results of this study support the existence of regulated CFTR trafficking which requires an appropriate balance between (i) internalization of CFTR into endocytic vesicles (endocytosis) and (ii) redistribution of internalized channels back to the plasma membrane (endocytic recycling). Wiskostatin and latrunculin B could affect the distribution of CFTR between these two compartments by (a) enhancing endocytosis from the cell surface, thereby increasing the intracellular pool of CFTR or (b) inhibiting recycling of endocytosed CFTR back to the cell surface (Fig. 7) . These possibilities are not mutually exclusive. An effect of wiskostatin on endocytosis is supported by the kinetic data (Fig. 6 ) which indicated that wiskostatin increased the fraction of surface-labeled CFTR that was endocytosed at early time points. It is possible that some CFTR at the cell surface is tethered to the actin cytoskeleton either directly [31] or indirectly via PDZ-domain interactions with proteins that bind actin (e.g., NHERF1/EBP50, NHERF2/ E3KARP and ezrin) [33] [34] [35] . Wiskostatin could increase the endocytic retrieval of CFTR by disrupting such interactions thereby increasing the proportion of surface CFTR that can be endocytosed. In support of this model, actin disruption by latrunculin A was proposed to release AMPA receptors from their anchoring to the post-synaptic membrane, thus allowing them to enter the perisynaptic endocytic pathway [36] . Such a putative mechanism would also be consistent with the observation that cyclic-AMP is able to inhibit CFTR internalization even in the presence of wiskostatin; depolymerization of actin by wiskostatin may untether CFTR from the cell surface, whereas cyclic-AMP may inhibit a downstream step in the endocytic pathway. Alternatively, wiskostatin could enhance the kinetics of internalization for an untethered population of CFTR, although this model would not be consistent with the reported positive role of N-WASP in regulating the endocytosis of other proteins [20] . Regarding a possible effect of wiskostatin on recycling, it is interesting to note that the endocytic accumulation of CFTR reached steadystate rapidly (within 2 min) under control conditions, suggesting that the internalized CFTR was efficiently recycled back to the cell surface under these conditions. In contrast, there was slow accumulation of CFTR in the wiskostatin-treated cells that reached steady-state very gradually (Fig. 6) . Thus, whether we assume all CFTR at the plasma membrane to be freely endocytosed or exist as two populations (tethered and untethered), one would have observed a rapid increase in the CFTR signal only in the initial few minutes if wiskostatin augmented the endocytic retrieval of CFTR alone. Therefore, the slower accumulation of CFTR in the wiskostatin-treated cells suggests that the recycling pathway had to be inhibited or saturated, which resulted in a net increase in the intracellular pool of CFTR. It is therefore likely that wiskostatin also compromises the recycling efficiency of CFTR. A more definitive conclusion would be possible if we could directly measure the recycling kinetics of CFTR in control and wiskostatin-treated cells. However, the rapid kinetics of CFTR endocytosis, especially in the wiskostatin-treated cells (Fig. 6) , precluded accurate measurements of the initial (unidirectional) rates of CFTR recycling in BHK cells (unpublished observations).
It is noteworthy that CFTR remained undegraded over a period of 2 h in the wiskostatin-treated cells, which suggests that the protein was possibly trapped in the recycling compartment (or an off-pathway compartment). Picciano et al., have reported that CFTR is trapped in an intracellular compartment when a regulator of membrane recycling (Rme-1) is inhibited [6] . Conceivably, wiskostatin could have similar effects. Preliminary results indicate that there is partial recovery of surface CFTR levels when cells are transferred to regular medium following wiskostatin treatment (data not shown), suggesting that CFTR is not permanently trapped within the cells.
In conclusion, the results reported in this paper implicate a role of N-WASP and actin in regulating CFTR expression and activity at the cell surface. Wiskostatin, an allosteric inhibitor of N-WASP activity, has potent and complex effects on CFTR endocytosis and recycling. The net effect was a marked redistribution of CFTR from the cell surface into intracellular compartments without CFTR degradation. Physiologic or pathologic factors (e.g., Rho-GTPase inhibitors, bacterial toxins, etc) that modulate N-WASP activity and influence actin assembly could influence CFTR surface expression by this mechanism.
